Corvine Chemicals And Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 20.00 Cr
- Paid Up Capital ₹ 9.45 Cr
- Company Age 32 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 81.07 Cr
- Satisfied Charges ₹ 10.87 Cr
- Revenue Growth -7.98%
- Profit Growth -21.11%
- Ebitda -20.20%
- Net Worth 11.83%
- Total Assets -2.29%
About Corvine Chemicals And Pharmaceuticals
Corvine Chemicals And Pharmaceuticals Private Limited (CCAPPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 22 June 1992 and has a history of 32 years and seven months. Its registered office is in Bidar, Karnataka, India.
The Corporate was formerly known as Corvine Chemicals Pvt Ltd. The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 20.00 Cr and a paid-up capital of Rs 9.45 Cr.
The company currently has active open charges totaling ₹81.07 Cr. The company has closed loans amounting to ₹10.87 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Corvine Chemicals And Pharmaceuticals Private Limited India is Smitha Borundia as COMPANY SECRETARY. Raji Kalva, Srinivas Bacha, Mahareddy Reddy, and One other member serve as directors at the Company.
Company Details
- Location
Bidar, Karnataka, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U85110KA1992PTC013271
- Company No.
013271
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
22 Jun 1992
- Date of AGM
27 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
What products or services does Corvine Chemicals And Pharmaceuticals Private Limited offer?
Corvine Chemicals And Pharmaceuticals Private Limited offers a wide range of products and services, including Pharma Ingredients & Raw Materials, Anti Infective API.
Who are the key members and board of directors at Corvine Chemicals And Pharmaceuticals?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Smitha Borundia  | Company Secretary | 01-Dec-2018 | Current |
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Mahareddy Reddy | Whole-Time Director | 10-Dec-2015 | Current |
| Bhanu Challa | Whole-Time Director | 01-Jun-2020 | Current |
| Raji Kalva | Director | 18-Nov-2012 | Current |
| Srinivas Bacha | Director | 01-Jun-2020 | Current |
Financial Performance of Corvine Chemicals And Pharmaceuticals.
Corvine Chemicals And Pharmaceuticals Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 7.98% decrease. The company also saw a substantial fall in profitability, with a 21.11% decrease in profit. The company's net worth Soared by an impressive increase of 11.83%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Corvine Chemicals And Pharmaceuticals?
In 2023, Corvine Chemicals And Pharmaceuticals had a promoter holding of 55.56% and a public holding of 44.44%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Vasavi Foundation For EmpowermentSrinivas Bacha is a mutual person
Naturite Agro Products LimitedSrinivas Bacha and Mahareddy Reddy are mutual person
Dr'.Curie's Labs LimitedRaji Kalva, Srinivas Bacha and 1 more are mutual person
- Prabhava Organics Private Limited
Raji Kalva, Srinivas Bacha and 2 more are mutual person
- Corvine Infra Llp
Srinivas Bacha, Mahareddy Reddy and 1 more are mutual person
- Fermi Chemicals Pvt Ltd
Srinivas Bacha and Mahareddy Reddy are mutual person
Charges (Loans)
₹81.07 Cr
₹10.87 Cr
Charges Breakdown by Lending Institutions
- Others : 45.00 Cr
- State Bank Of India : 34.57 Cr
- Hdfc Bank Limited : 1.50 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 31 May 2023 | Hdfc Bank Limited | ₹1.50 Cr | Open |
| 01 Jun 2022 | Others | ₹45.00 Cr | Open |
| 22 Dec 1999 | State Bank Of India | ₹34.57 Cr | Open |
| 10 Nov 2020 | Hdfc Bank Limited | ₹8.70 M | Satisfied |
| 22 Apr 2020 | Others | ₹5.00 Cr | Satisfied |
How Many Employees Work at Corvine Chemicals And Pharmaceuticals?
Corvine Chemicals And Pharmaceuticals has a workforce of 115 employees as of Mar 22, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Corvine Chemicals And Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Corvine Chemicals And Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
